“…The midbrain dopamine (DA) system has been implicated in reinforcement learning, reward prediction error ( Schultz et al, 1997 ), motivation ( Berke, 2018 ), incentive salience ( Berridge and Robinson, 1998 ) and in diseases where these functions are compromised, such as substance use disorder ( Lüscher, 2016 ). Expanding on the classical classification of DA circuits into nigrostriatal and mesolimbic systems ( Björklund and Dunnett, 2007 ), recent studies have focused on the heterogeneity of DA neurons within the midbrain, in terms of gene expression, projection patterns and behavioral role ( Chung et al, 2005 ; Greene et al, 2005 ; Lammel et al, 2008 , 2011 , 2012 ; Poulin et al, 2014 , 2018 ; Viereckel et al, 2016 ; Bimpisidis et al, 2019 ; Heymann et al, 2020 ; König et al, 2020 ; Serra et al, 2021 ). Characterizing differences between previously considered homogeneous DA populations will lead in deciphering the functional role of distinct subpopulations, make it possible to selectively target them for treatment of disease and eventually avoiding unwanted side effects that might occur by targeting the DA system as a whole.…”